261 related articles for article (PubMed ID: 11516878)
1. Advancements in cancer therapy with alpha-emitters: a review.
Imam SK
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):271-8. PubMed ID: 11516878
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
3. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
4. An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Ferrier MG; Radchenko V
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S58-S65. PubMed ID: 31427258
[No Abstract] [Full Text] [Related]
5. Radioimmunotherapy with alpha-particle emitting radioimmunoconjugates.
Zalutsky MR; Bigner DD
Acta Oncol; 1996; 35(3):373-9. PubMed ID: 8679269
[TBL] [Abstract][Full Text] [Related]
6. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
Allen BJ
Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy with alpha-emitting nuclides.
McDevitt MR; Sgouros G; Finn RD; Humm JL; Jurcic JG; Larson SM; Scheinberg DA
Eur J Nucl Med; 1998 Sep; 25(9):1341-51. PubMed ID: 9724387
[TBL] [Abstract][Full Text] [Related]
8. Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
Zalutsky MR; Schuster JM; Garg PK; Archer GE; Dewhirst MW; Bigner DD
Recent Results Cancer Res; 1996; 141():101-22. PubMed ID: 8722422
[No Abstract] [Full Text] [Related]
9. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
10. Radionuclides for radioimmunotherapy: criteria for selection.
Geerlings MW
Int J Biol Markers; 1993; 8(3):180-6. PubMed ID: 8277210
[TBL] [Abstract][Full Text] [Related]
11. Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
Morgenstern A; Bruchertseifer F; Apostolidis C
Curr Radiopharm; 2012 Jul; 5(3):221-7. PubMed ID: 22642390
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
13. Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.
Bruchertseifer F; Kellerbauer A; Malmbeck R; Morgenstern A
J Labelled Comp Radiopharm; 2019 Sep; 62(11):794-802. PubMed ID: 31369165
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy with α-particle-emitting radionuclides.
Seidl C
Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
[TBL] [Abstract][Full Text] [Related]
15. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion protein.
Miederer M; Seidl C; Beyer GJ; Charlton DE; Vranjes-Duric S; Comor JJ; Huber R; Nikula T; Apostolidis C; Schuhmacher C; Becker KF; Senekowitsch-Schmidtke R
Radiat Res; 2003 May; 159(5):612-20. PubMed ID: 12710872
[TBL] [Abstract][Full Text] [Related]
17. Ac-225 and her daughters: the many faces of Shiva.
McDevitt MR; Scheinberg DA
Cell Death Differ; 2002 Jun; 9(6):593-4. PubMed ID: 12032666
[No Abstract] [Full Text] [Related]
18. Development of Targeted Alpha Therapy from Bench to Bedside.
Morgenstern A; Bruchertseifer F
J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S18-S20. PubMed ID: 31405818
[TBL] [Abstract][Full Text] [Related]
19. Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.
Vaidyanathan G; Zalutsky MR
Curr Radiopharm; 2011 Oct; 4(4):283-94. PubMed ID: 22202151
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy using alpha emitters.
Vaidyanathan G; Zalutsky MR
Phys Med Biol; 1996 Oct; 41(10):1915-31. PubMed ID: 8912371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]